Mitochondrial Dysfunction in Podocyte Pathophysiology

Podocytes are highly specialised epithelial cells that wrap around the glomerular capillaries and form a critical component of the kidney’s filtration barrier. Their elaborate interdigitating foot processes demand considerable energy to maintain cytoskeletal architecture, slit‐diaphragm integrity and dynamic barrier function. Mitochondria within podocytes serve as the principal source of ATP via oxidative phosphorylation, while cytosolic glycolysis contributes to local energy requirements at peripheral structures. Disturbances in mitochondrial biogenesis, dynamics (fission and fusion), membrane potential and reactive oxygen species (ROS) balance precipitate alterations in cellular metabolism, trigger foot process effacement and promote apoptosis. Such mitochondrial dysfunction underlies major glomerular diseases, including diabetic kidney disease and focal segmental glomerulosclerosis, where impaired oxidative phosphorylation, excessive ROS and defective mitophagy converge to drive podocyte loss and proteinuria. Regulatory nodes—such as PGC-1α-mediated biogenesis, mTOR signalling, receptor‐mediated metabolic reprogramming and mitochondrial quality control pathways—emerge as both mechanistic insights and therapeutic targets. Interventions that restore mitochondrial function, enhance antioxidant defences or promote selective autophagic clearance of damaged organelles hold promise for halting podocyte injury and the progression of chronic kidney disease on a global scale.

Research from Nature Portfolio

Two foundational studies have clarified the metabolic compartmentalisation in podocytes and the therapeutic potential of mitophagy modulation in glomerular disease models. One investigation revealed that differentiated podocytes rely predominantly on glycolysis to fuel lamellipodial and foot‐processing structures, whereas mitochondrial ATP production supports central cell body functions, highlighting parallel but distinct energy pathways for cytoskeletal maintenance. A second study demonstrated that enhancement of PINK1–Parkin-mediated mitophagy markedly reduces mitochondrial fragmentation and apoptosis in membranous nephropathy models, underscoring mitophagy as a promising strategy to preserve podocyte architecture and attenuate albuminuria.

Mitochondrial Dysfunction in Podocyte Pathophysiology publication trend

The graph below shows the total number of articles in mitochondrial dysfunction in podocyte pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Podocyte: A specialised epithelial cell in the kidney glomerulus that maintains the blood–urine filtration barrier.

Mitochondrial oxidative phosphorylation (OXPHOS): The process by which mitochondria generate ATP through electron transport and a proton gradient.

Mitophagy: Selective degradation of dysfunctional mitochondria by autophagy to preserve cellular health.

Reactive oxygen species (ROS): Highly reactive oxygen-derived molecules that can damage proteins, lipids and DNA when unregulated.

ATP (adenosine triphosphate): The principal energy currency of the cell produced by mitochondria and cytosolic pathways.

References

1. Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes. Scientific Reports (2015).
2. Jianpi Qushi Heluo Formula alleviates renal damages in Passive Hemann nephritis in rats by upregulating Parkin-mediated mitochondrial autophagy. Scientific Reports (2021).
3. LRH‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2‐mediated glutaminolysis. Cell Proliferation (2023).
4. Mitoquinone Protects Podocytes from Angiotensin II‐Induced Mitochondrial Dysfunction and Injury via the Keap1‐Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity (2021).
5. Mitochondrial Dysfunction in Podocytes Caused by CRIF1 Deficiency Leads to Progressive Albuminuria and Glomerular Sclerosis in Mice. International Journal of Molecular Sciences (2021).